DIANA WILLIFORD: Open Payments
NPI 1497535967 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 81 payments from 8 companies in 2025. Trend: 2023 $153 · 2024 $1,397 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $279 |
| Teva Pharmaceuticals USA, Inc. | 10 | $232 |
| ABBVIE INC. | 20 | $224 |
| Neurocrine BioSciences, Inc. | 14 | $184 |
| Alkermes, Inc. | 11 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $156 |
| Lundbeck LLC | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, UZEDY, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
